Transindia Real Estate Limited (NSE:TREL)

Market Cap	8.18B
Revenue (ttm)	788.50M
Net Income (ttm)	553.50M
Shares Out	245.70M
EPS (ttm)	2.43
PE Ratio	13.06
Forward PE	n/a
Dividend	1.00 (3.02%)
Ex-Dividend Date	n/a

Volume	30,248
Average Volume	99,579
Open	33.61
Previous Close	33.10
Day's Range	33.05 - 33.75
52-Week Range	24.73 - 52.64
Beta	-0.14
RSI	44.40
Earnings Date	Jul 30, 2025

About Revance Therapeutics

Transindia Real Estate Limited, a real estate company, engages in the development and leasing of land and commercial properties, logistics park, and warehouse. It also involved in the engineering and equipment hiring solutions; and other related business. The company was formerly known as Transindia Realty & Logistics Parks Limited and changed its name to TransIndia Real Estate Limited in May 2023. Transindia Real Estate Limited is based in Mumbai, India.

• Industry: Real Estate Services
• Sector: Real Estate
• CEO: Ram Walase
• Employees: 35
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: TREL

Financial Performance

In 2024, Transindia Real Estate's revenue was 826.30 million, a decrease of -14.66% compared to the previous year's 968.20 million. Earnings were 526.30 million, a decrease of -78.98%.